NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./ OXFORD, Ohio and DENVER, Dec. 1, 2022 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an intellectual property driven biotechnology company focused on discovery and…

Source

Previous articleFILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES
Next articleNuminus Wellness Inc. Reports Q4 2022 and Annual Results